Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma
Clinical trial NCT04402138 · COMPLETED
Trial details
- NCT number
- NCT04402138
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-07
- Primary completion
- 2024-04-05
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.